Denne hjemmeside kræver, at JavaScript er aktiveret for at fungere korrekt. Rediger dine indstillinger eller brug en anden browser til at fortsætte.

      

Du forlader nu GSK’s hjemmeside

Ved at klikke på dette link, kommer du til en hjemmeside, som ikke er ejet eller kontrolleret af GSK.

Fortsæt

Gå tilbage

Søgeresultater for
1 - 0 af 167 emner
25-10-2018

Møder

18-03-2018

Site map

25-10-2018

Unsubscribe Success

25-09-2018

Skift adgangskode

25-09-2018

Delete Account

25-09-2018

Profil

10-03-2018

Brugerbetingelser

25-10-2018

Access GSK Page

26-10-2018

Data Layer test

25-09-2018

Basket

25-09-2018

Ordrehistorik

25-09-2018

Products Samples

27-09-2018

Order Confirmation

25-09-2018

Logud

10-03-2018

Other Events

10-03-2018

Basket

10-03-2018

isa

11-10-2018

products

18-03-2018

Glossary

18-03-2018

Living with asthma

26-12-2018

Recognising the impact of asthma

For Healthcare professionals. Inside Severe Asthma – educational information on asthma impact, asthma pathalogy and development, cost and community burden
18-03-2018

Severe asthma morbidity and mortality

For Healthcare professionals. Inside Severe Asthma – educational information on asthma impact, asthma pathalogy and development, cost and community burden
26-12-2018

About biologics

26-12-2018

Using biologics

For Healthcare professionals. Inside Severe Asthma – educational information on severe asthma biologics, eosinophils, IL-5 and their role in severe asthma
26-12-2018

About this programme

For Healthcare professionals. Inside Severe Asthma – a programme aiming to transform the diagnosis and treatment of severe asthma
26-12-2018

Inside Severe Asthma

For Healthcare professionals. Information about severe asthma programme, expert videos, latest news and materials for download.
26-12-2018

Treating by phenotype

For Healthcare professionals. Inside Severe Asthma – educational information on severe asthma phenotyping and biomarkers
26-12-2018

Severe refractory eosinophilic asthma study (DREAM)

For Healthcare professionals. Inside Severe Asthma – educational information on severe asthma studies - Dream, Mensa, Sirius, Cosmos
26-12-2018

Exacerbation reduction study (MENSA)

For Healthcare professionals. Inside Severe Asthma – educational information on severe asthma studies - Dream, Mensa, Sirius, Cosmos
18-03-2018

Long-term efficacy and safety of mepolizumab (COSMOS)

For Healthcare professionals. Inside Severe Asthma – educational information on severe asthma studies - Dream, Mensa, Sirius, Cosmos
18-03-2018

Mepolizumab dose

For Healthcare professionals. Inside Severe Asthma – educational information on severe asthma studies - Dream, Mensa, Sirius, Cosmos
26-12-2018

Oral corticosteroid-sparing study (SIRIUS)

For Healthcare professionals. Inside Severe Asthma – educational information on severe asthma studies - Dream, Mensa, Sirius, Cosmos
26-12-2018

Mepolizumab clinical data

For Healthcare professionals. Inside Severe Asthma – educational information on severe asthma studies - Dream, Mensa, Sirius, Cosmos
26-12-2018

Programme overview

For Healthcare professionals. Inside Severe Asthma – educational information on severe asthma studies - Dream, Mensa, Sirius, Cosmos
26-12-2018

Expert videos

For Healthcare professionals. Inside Severe Asthma – videos with leading experts talking about severe asthma phenotypes
21-02-2019

Educational materials

For Healthcare professionals. Inside Severe Asthma – educational materials on severe asthma for download
28-12-2018

Guidelines

For Healthcare Professionals: View HIV treatment guidelines
28-12-2018

HIV

For Healthcare Professionals: Welcome to the HIV therapy area. Here you can access the latest information on our HIV portfolio.
07-05-2018

Videos

28-12-2018

dtg moa

02-01-2019

SAILING, 48 weeks

02-01-2019

SPRING-2, 96 weeks

07-05-2018

Publications

07-05-2018

VIKING-3, 24 weeks

28-12-2018

STRIIVING, 48 weeks

02-01-2019

FLAMINGO, 96 weeks

28-12-2018

Dolutegravir-based regimens

For Healthcare Professionals: Learn about the advantages of dolutegravir as the core agent in antiretroviral treatment
02-01-2019

Terapiområder

27-08-2019

Publikationer – Salford Lung Study

Til sundhedspersoner: Information om Salford Lung Study
24-12-2018

Publikationer

18-03-2018

Ofte stillede spørgsmål om Ellipta®

Til sundhedspersonale. Brug af Ellipta, spørgsmål og svar om Ellipta
24-12-2018

Inhalatorer

For sundhedspersonale. Om inhalatorerne Ellipta®, Diskos® og Inhalationsspray
24-12-2018

Ellipta

For sundhedspersonale. Praktisk brug af Ellipta®
24-12-2018

Ofte stillede spørgsmål om Diskos®

Til sundhedspersonale. Brug af Ellipta, spørgsmål og svar om Ellipta
24-12-2018

Se hvordan Ellipta-inhalatoren fungerer

Information til sundhedspersoner om inhalatoren Ellipta®
24-12-2018

Diskos®

Til sundhedspersonale. Hvordan bruges Diskos®
24-12-2018

Sådan benytter du din Ellipta

Information til sundhedspersoner om pragtisk brug av inhalatoren Ellipta®
24-12-2018

Publikationer – Salford Lung Study

Til sundhedspersoner: Information om Salford Lung Study
24-12-2018

Guidelines

Information til sundhedspersoner med links til danske og internationale guidelines
24-12-2018

Produktoversigt

For sundhedspersonale. GSK portefølje – Relvar, Anoro, Incruse, Nucala, Seretide, Flixotide, Serevent, Ventoline, Avamys
24-12-2018

Respiration - oversigt

Oversigt over GSK’s produktportefølje a inhalatorer til brug i behandling af astma og KOL, ekspertvideoer, retningslinjer, patientmateriale
09-05-2019

COPD Expert videos

10-03-2018

Brug af cookies

22-07-2019

Consent Management

25-10-2018

GSK nyheder

17-12-2018

Ordinering

17-12-2018

Publikationer

17-12-2018

Anoro Ellipta

umeclidinium/vilanterol <br>Respiratoriske sygdomme & allergi</br>
02-01-2019

Key study data

02-01-2019

Safety data

17-12-2018

Aktuelle film

17-12-2018

Effekt og bivirkningsdata

Information & ressourcer om Anoro Ellipta (umeclidinium/vilanterol) til gavn for sundhedspersoner
17-12-2018

Produktoversigt

17-12-2018

Retningslinier

Information for healthcare professionals: COPD Guidelines and disease management
18-12-2018

Tivicay

Dolutegravir<br>HIV
18-12-2018

How to prescribe?

For Healthcare Professionals: Access the latest data and resources and learn how to prescribe Tivicay (dolutegravir).
18-12-2018

Adverse Events

For Healthcare Professionals: Learn about Tivicay (dolutegravir) adverse events
05-12-2018

Incruse Ellipta

umeclidinium <br>Respiratoriske sygdomme & allergi</br>
27-08-2019

Relvar Ellipta

fluticasonfuroat/vilanterol <br>Respiratoriske sygdomme & allergi</br>
27-08-2019

Produkter

17-12-2018

How to prescribe?

For Healthcare Professionals: Learn about prescribing JULUCA (dolutegravir/rilpivirine)
29-08-2018

Guidelines

For Healthcare Professionals: Learn more about DTG+RPV in HIV treatment guidelines
17-12-2018

Juluca

dolutegravir/rilpivirine <br>HIV</br>
17-12-2018

Why DTG+RPV?

For Healthcare Professionals: Learn more about JULUCA (dolutegravir/rilpivirine) – Why DTG+RPV?
17-12-2018

Efficacy and tolerability

For Healthcare Professionals: Learn more about JULUCA (dolutegravir/rilpivirine) efficacy and tolerability
17-12-2018

The 2DR

For Healthcare Professionals: Learn more about the new 2-drug regimen era
18-12-2018

How to prescribe?

18-12-2018

Safety

For Healthcare Professionals: Learn about Triumeq (dolutegravir/abacavir/lamivudine) safety
09-04-2018

Ofte stillede spørgsmål

egnede patienter med KOL. Svar på ofte stillede spørgsmål.Information til sundhedspersoner: Trelegy Ellipta - en triplebehandling til
18-12-2018

Overblik

Information til sundhedspersoner: Trelegy Ellipta - en triplebehandling til egnede patienter med KOL. Produktoverblik.
18-12-2018

Trelegy

fluticasonfuroat/umeclidinium/vilanterol <br>Respiratoriske sygdomme</br>
18-12-2018

Ordinering

Information til sundhedspersoner: Produktinformation og dosering Trelegy Ellipta – en triplebehandling til egnede patienter med KOL.
18-12-2018

Effekt og bivirkninger

Information til sundhedspersoner: Trelegy Ellipta - a trestofbehandling til egnede patienter med KOL. Effekt og birvirkninger
17-12-2018

Dosage and administration

For healthcare professionals: Guidance about preparing and administering Nucala targeted add-on asthma treatment for adult patients with severe refractory eosinophilic asthma
17-12-2018

Disease

For healthcare professionals: The role of eosinophils in patients with severe eosinophilic asthma, identification and associated symptoms of eosinophilic asthma
17-12-2018

Mode of action animation

Mode of action animation
17-12-2018

Product overview

For healthcare professionals: Prescription medicine Nucala, the first targeted anti-IL-5 add-on therapy for your adult patients with severe refractory eosinophilic asthma
17-12-2018

FAQs

For healthcare professionals: Frequently asked questions (FAQs) about severe refractory eosinophilic asthma and Nucala treatment including patient identification, asthma attacks, Nucala safet, dosing and administration
17-12-2018

Core SEA Data

Nucala reduced clinically significant exacerbations (MENSA primary endpoint) and patients’ daily oral corticosteroid (OCS) dose, while maintaining asthma control (SIRIUS primary endpoint) vs. placebo, when both were added to high dose ICS and an additional maintenance treatment(s).1 1. Nucala [draft] SmPC, 2015.
17-12-2018

How it works

Learn how Nucala, a targeted treatment for severe refractory eosinophilic asthma in adult patients works.
17-12-2018

SEA Study summaries

For healthcare professionals: Information on the efficacy and safety data from the Nucala Phase II and III clinical studies (DREAM, MENSA and SIRIUS)
17-12-2018

Efficacy and safety

For healthcare professionals: Safety and efficacy of Nucala as an add-on therapy for adult patients with severe refractory eosinophilic asthma
17-12-2018

Nucala

mepolizumab <br>Respiratoriske sygdomme</br>
17-12-2018

Videos

17-12-2018

Practial tools

For healthcare professionals: Online tools to identify if your severe refractory asthma patient may be eligible to receive Nucala, the first targeted anti-IL-5 add-on therapy for your adult patients with severe refractory eosinophilic asthma
17-12-2018

Patient identification

For healthcare professionals: Identifying adult patients with severe refractory eosinophilic asthma who may benefit from targeted anti-IL-5 add-on treatment with Nucala
25-09-2018

Login

26-09-2018

Login

25-09-2018

Login

25-09-2018

Reset Password

25-09-2018

Update Password

25-09-2018

Glemt adgangskode

Venligst indtast din e-mailadresse, og du vil herefter modtage en e-mail med en midlertidig adgangskode
25-09-2018

Opret profil

18-03-2018

Kontakt os

10-03-2018

campaigns

18-03-2018

Søgeresultat

25-10-2018

Unsubscribe Success

02-01-2019

Bestil materiale

1 - 0 af 167 emner

Vis mere

Ingen resultater for din valgte søgning. Prøv at:

  • kontrollere stavningen af ​​søgeordet
  • skrive et andet søgeord
  • nulstille eller ændre filterindstillingerne (hvis du brugte filtre til denne søgning)